FDA closes probe into Cyclospora outbreak

On Oct. 2, 2026, the U.S. Food and Drug Administration announced the conclusion of its investigation into a summer outbreak of Cyclospora infections. The agency linked the illnesses to recalled shredded iceberg lettuce produced by Taylor Farms de Mexico. This finding followed a multi-step traceback and inspection effort focused on where the implicated lettuce was grown and processed.

The conclusion of the probe marks the end of an intensive investigation into the source of the parasite in the supply chain. Regulators emphasized the connection to specific lettuce products while noting that the investigation has now formally closed.

During inspections in Mexico, investigators collected environmental samples from the Taylor Farms de Mexico processing facility and associated growing areas. Two of these samples tested positive for Cyclospora. One positive result came from a tank holding outgoing wastewater at the processing facility.

The second positive sample was taken from a drainage ditch at an iceberg lettuce grower identified during traceback work. The presence of Cyclospora in both the processing wastewater and grower drainage indicates that the parasite was present in the environment connected to the affected lettuce.

These environmental detections provided important supporting evidence tying the outbreak to the shredded iceberg lettuce. However, they did not by themselves establish the precise route by which contamination reached the finished product.

Despite the positive environmental samples, FDA reported that it could not definitively determine how the contamination of the lettuce occurred. Possible points in the growing, harvesting, or processing environment remain under consideration, but no single mechanism has been established.

Genotyping of the two positive environmental samples has been completed. FDA is continuing its analysis to compare these genotypes with clinical specimens collected from patients during the outbreak. This comparison is intended to clarify the relationship between the environmental detections and human cases.

The ongoing genotyping comparison work continues even as the main field investigation has been closed, reflecting an effort to refine the scientific understanding of the outbreak source.

Alongside closing the investigation, FDA announced a set of post-outbreak prevention actions. These include a 10-point plan designed to reduce the risk of future Cyclospora contamination events linked to leafy greens such as iceberg lettuce.

The agency indicated it will increase monitoring and outreach to industry and other stakeholders as part of these measures. The efforts are aimed at the growing and processing stages ahead of the 2027 growing season, with a focus on preventing a recurrence of similar outbreaks.

By pairing its investigative findings with targeted prevention steps, FDA is seeking to translate lessons from the Cyclospora outbreak into concrete risk-reduction actions in the lettuce supply chain.